Epoch 2: Sailing Through the Biotech Storm, Shorelines Spotted?

mAbs & Jabs, New Drugs, M&A

Welcome to the 117 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 1039 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:

Hello Avatar! Welcome back for another week of biotech analysis.  This week was a big one for the industry as the JP Morgan Healthcare Conference …